Hence, providing confirmation that the dynamic detection of IL-17A and IL-35 expression levels in BALF has the potential to provide valuable clinical clues and observations for the development and severity of CIP. The gene discussed is IL17A; the disease is hereditary sensory and autonomic neuropathy.